
    
      Participant eligibility will be screened at visit 1. The study will be a randomized,
      cross-over design. Participants will come to the study site on 5 separate occasions separated
      by a 2-day to 2-week washout period. Participants will arrive to the lab in a fasted state. 2
      fasting blood samples will be collected, and further blood sampled will be taken over a
      3-hour period post study product consumption.
    
  